1. Home
  2. CRGX vs PWOD Comparison

CRGX vs PWOD Comparison

Compare CRGX & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • PWOD
  • Stock Information
  • Founded
  • CRGX 2021
  • PWOD 1934
  • Country
  • CRGX United States
  • PWOD United States
  • Employees
  • CRGX N/A
  • PWOD N/A
  • Industry
  • CRGX
  • PWOD Major Banks
  • Sector
  • CRGX
  • PWOD Finance
  • Exchange
  • CRGX Nasdaq
  • PWOD Nasdaq
  • Market Cap
  • CRGX 180.4M
  • PWOD 193.1M
  • IPO Year
  • CRGX 2023
  • PWOD N/A
  • Fundamental
  • Price
  • CRGX $4.64
  • PWOD $26.39
  • Analyst Decision
  • CRGX Hold
  • PWOD
  • Analyst Count
  • CRGX 7
  • PWOD 0
  • Target Price
  • CRGX $4.67
  • PWOD N/A
  • AVG Volume (30 Days)
  • CRGX 653.7K
  • PWOD 28.1K
  • Earning Date
  • CRGX 05-13-2025
  • PWOD 04-24-2025
  • Dividend Yield
  • CRGX N/A
  • PWOD 4.86%
  • EPS Growth
  • CRGX N/A
  • PWOD 0.64
  • EPS
  • CRGX N/A
  • PWOD 2.35
  • Revenue
  • CRGX N/A
  • PWOD $68,377,000.00
  • Revenue This Year
  • CRGX $58.18
  • PWOD N/A
  • Revenue Next Year
  • CRGX N/A
  • PWOD N/A
  • P/E Ratio
  • CRGX N/A
  • PWOD $11.23
  • Revenue Growth
  • CRGX N/A
  • PWOD 6.11
  • 52 Week Low
  • CRGX $3.00
  • PWOD $17.01
  • 52 Week High
  • CRGX $25.45
  • PWOD $34.56
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 59.08
  • PWOD 41.97
  • Support Level
  • CRGX $3.58
  • PWOD $25.08
  • Resistance Level
  • CRGX $4.17
  • PWOD $26.63
  • Average True Range (ATR)
  • CRGX 0.26
  • PWOD 1.01
  • MACD
  • CRGX 0.12
  • PWOD 0.01
  • Stochastic Oscillator
  • CRGX 92.98
  • PWOD 44.86

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

Share on Social Networks: